ArticleJournal, genetic engineering & biotechnology2025
Utilizing deep learning algorithms for the early identification and categorization of skin cancer.
Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer is one of the utmost global challenges for today human being. Diverse forms of skin cancer found in humans, but current research work focuses on malignancy. The malignant can be treated easily if detected in the early stage. To achieve this goal, image processing and deep learning techniques were performed for the distinguished melanoma in early stages. Utilizing three models such as EfficientNet-B0, VGG16, and Inception-V3, the process involved initial preprocessing of image followed by training these models for 30 epochs on the PH2 and ISIC datasets. All three models demonstrated strong performance on both dataset; however, EfficientNet-B0 outperformed the other two models with an accuracy of 92 %, while Inception-V3 achieved 87 % accuracy and VGG-16 achieved 85 % accuracy. It has been established from the results that we aspire to enhance our suggested idea by incorporating it into a mobile platform in forthcoming endeavors. This modification will allow users to access and employ the model's capabilities on the go, enhancing its reach and impact. The mobile platform will have an easy-to-use interface, allowing users to provide data and get reliable outcomes. This integration will not only increase the accessibility of the model, but also improve its value, making it easier for individuals to adopt it into their daily lives. By doing so, we hope to boost the model's adoption and utilization, resulting in more accurate predictions and better decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.